Baricitinib research and development history, market price and drug purchase guidelines

Baricitinib (Baricitinib), an oral small molecule Janus kinase (JAK) inhibitor, was jointly developed by Eli Lilly and Incyte. Since its launch, it has demonstrated excellent therapeutic effects in dealing with autoimmune diseases such as rheumatoid arthritis, COVID-19, and alopecia areata. This article aims to comprehensively explain the research and development process, market price and drug purchase guidelines of baricitinib to help patients have a deeper understanding of and rational use of this drug.

1. R&D process

The birth of baricitinib stems from in-depth exploration of the mechanisms of autoimmune diseases. JAKs, as important members of intracellular non-receptor tyrosine kinases, include JAK1, JAK2, JAK3 and Tyk2. They play a pivotal role in the signaling of inflammatory diseases. By precisely inhibiting JAK1 and JAK2, baricitinib effectively regulates the immune response and reduces inflammation, opening up new ways for the treatment of various autoimmune diseases. Since 2009, Incyte Pharmaceuticals in the United States and Eli Lilly Pharmaceuticals have worked together to jointly promote the research and development of baricitinib. After years of clinical verification and safety evaluation, baricitinib was approved in the European Union, the United Kingdom and Japan in 2017 for the treatment of moderate to severe rheumatoid arthritis. In 2018, the US FDA also approved its marketing application. By 2022, baricitinib has received FDA breakthrough therapy certification for the treatment of severe alopecia areata in adults.

2. Market price

The market price of baricitinib varies by region, specification and sales channel. Typically, brand-name drugs are more expensive, but with the emergence of generic drugs, patients have more affordable options. Taking the Chinese market as an example, the price of baricitinib is roughly more than 1,000 yuan per box, and the specific price fluctuates depending on the sales channel. For patients under greater financial pressure, generic drugs may be a more practical option. For example, baricitinib produced by Bangladesh General Pharmaceutical Factory contains 2mg*30 tablets per box and sells for about 200 yuan.

3. Drug Purchasing Guidelines

When purchasing baricitinib, patients should pay attention to the following:

1. Choose formal channels: Make sure to purchase original medicines from regular pharmacies, hospital pharmacies or online pharmacies to avoid fake and shoddy products. For generic drugs, you can consult professional overseas medical institutions.

2. Understand drug details: Before purchasing, you should learn more about the indications, usage and dosage, possible adverse reactions and contraindications of the drug to ensure that the drug matches your condition.

3. Purchased with a prescription: Baricitinib is a prescription drug and must be purchased with a prescription issued by a doctor. When purchasing, please present the prescription and inform the pharmacist of your condition and medication history.

4. Pay attention to price factors: Understand the market price of drugs and choose products with high cost performance. At the same time, pay attention to medical insurance policies and generic drug information to reduce the financial burden.

In summary, baricitinib, as an effective treatment drug, provides patients with more treatment options. When purchasing and using, patients should fully understand drug information, choose formal channels, purchase with prescriptions, and pay attention to drug prices and specifications. Through rational medication and scientific health management, patients can more effectively control their conditions and improve their quality of life.